 Gilead Sciences, Inc. NASDAQ: GILD and its RD partner Galapagos ADR Representing Ord Shs NASDAQ: GLPG received an upgrade each from Morgan Stanley. The Gilead, Galapagos Analyst: Matthew Harrison upgraded Gilead from Equal-weight from Overweight and increased the price target from 67 to 83. 